Fig. 7 | Scientific Reports

Fig. 7

From: Multi-omics analysis identifies LANCL2 as a potential biomarker for the diagnosis and prognosis of gastric cancer

Fig. 7

The correlation between LANCL2 expression level and multidrug sensitivity. (A) Comparison of the differences in drug sensitivity between LANCL2 high expression group and low expression group in STAD based on the GDSC database. (B) The correlation between LANCL2 expression and the sensitivity of drugs in pan-cancer through the GSCA database. (*P < 0.05, **P < 0.01, ***P < 0.001).

Back to article page